Tissue-specific effects of the nuclear factor κB subunit p50 on myocardial ischemia-reperfusion injury

被引:79
作者
Frantz, Stefan
Tillmanns, Jochen
Kuhlencordt, Peter J.
Schmidt, Isabel
Adamek, Anna
Dienesch, Charlotte
Thum, Thomas
Gerondakis, Steve
Ertl, Georg
Bauersachs, Johann
机构
[1] Univ Wurzburg, Med Klin & Poliklin 1, Herz Kreislaufzentrum, D-97080 Wurzburg, Germany
[2] Walter & Eliza Hall Inst Med Res, Parcville, Vic, Australia
关键词
D O I
10.2353/ajpath.2007.061042
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Nuclear factor KB (NF-kappa B) is a ubiquitous transcription factor activated by various stimuli implicated in ischemia-reperfusion injury. However, the role of NF-kappa B in cardiac ischemia-reperfusion injury has not yet been well defined. Therefore, we investigated reperfusion damage in mice with targeted deletion of the NF-KB subunit p50. Electrophoretic mobility shift assays validated NF-KB activation in wild-type (wi) but not P50 knockout (KO) mice. KO and WT animals underwent 30 minutes of coronary artery ligation and 24 hours of reperfusion in vivo. Ischemia-reperfusion damage was significantly reduced in the P50 KO when compared with matching WT mice. Although adhesion molecules such as intercellular adhesion molecule were up-regulated in left ventricles of P50 KO animals, fewer neutrophils infiltrated the infarct area, suggesting leukocytes as a potential mediator of the protection observed in the p50 KO. This was confirmed in adoptive transfer experiments: whereas transplantation of KO bone marrow in KO animals sustained the protective effect on ischemia-reperfusion injury, transplantation of WT bone marrow in KO animals abolished it. Thus, deletion of the NF-kappa B subunit p50 reduces ischemia-reperfusion injury in vivo, associated with less neutrophil infiltration. Bone marrow transplantation experiments indicate that impaired NF-KB activation in P50 KO leukocytes attenuates cardiac damage.
引用
收藏
页码:507 / 512
页数:6
相关论文
共 32 条
[1]   EMBRYONIC LETHALITY AND LIVER DEGENERATION IN MICE LACKING THE RELA COMPONENT OF NF-KAPPA-B [J].
BEG, AA ;
SHA, WC ;
BRONSON, RT ;
GHOSH, S ;
BALTIMORE, D .
NATURE, 1995, 376 (6536) :167-170
[2]   In vivo cardioprotection by N-acetylcysteine and isosorbide 5-mononitrate in a rat model of ischemia-reperfusion [J].
Calvillo, L ;
Masson, S ;
Salio, M ;
Pollicino, L ;
De Angelis, N ;
Fiordaliso, F ;
Bai, A ;
Ghezzi, P ;
Santangelo, F ;
Latini, R .
CARDIOVASCULAR DRUGS AND THERAPY, 2003, 17 (03) :199-208
[3]   Induction of nuclear factor kappa B and activation protein 1 in postischemic myocardium [J].
Chandrasekar, B ;
Freeman, GL .
FEBS LETTERS, 1997, 401 (01) :30-34
[4]  
Chandrasekar B, 2001, CIRCULATION, V103, P2296
[5]   The cyclopentenone prostaglandin 15-deoxy-Δ12,14-prostaglandin J2 ameliorates ischemic acute renal failure [J].
Chatterjee, PK ;
Patel, NSA ;
Cuzzocrea, S ;
Brown, PAJ ;
Stewart, KN ;
Mota-Filipe, H ;
Britti, D ;
Eberhardt, W ;
Pfeilschifter, J ;
Thiemermann, C .
CARDIOVASCULAR RESEARCH, 2004, 61 (03) :630-643
[6]   Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis [J].
Coletta, PL ;
Müller, AM ;
Jones, EA ;
Mühl, B ;
Holwell, S ;
Clarke, D ;
Meade, JL ;
Cook, GP ;
Hawcroft, G ;
Ponchel, F ;
Lam, WK ;
MacLennan, KA ;
Hull, MA ;
Bonifer, C ;
Markham, AF .
BLOOD, 2004, 103 (03) :1050-1058
[7]   Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury:: prevention by the α-glucosidase inhibitor acarbose [J].
Frantz, S ;
Calvillo, L ;
Tillmanns, J ;
Elbing, I ;
Dienesch, C ;
Bischoff, H ;
Ertl, G ;
Bauersachs, J .
FASEB JOURNAL, 2005, 19 (01) :591-+
[8]   Innate immunity and the heart [J].
Frantz, S ;
Bauersachs, J ;
Kelly, RA .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (10) :1279-1290
[9]   Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction [J].
Frantz, S ;
Hu, K ;
Widder, J ;
Bayer, B ;
Witzel, CC ;
Schmidt, I ;
Galuppo, P ;
Strotmann, J ;
Ertl, G ;
Bauersachs, J .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (01) :9-14
[10]   Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium [J].
Frantz, S ;
Kobzik, L ;
Kim, YD ;
Fukazawa, R ;
Medzhitov, R ;
Lee, RT ;
Kelly, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :271-280